The WWRD Study: AVM0703 for Treatment of Leukemia or Lymphoma

Condition:   Lymphoid Malignancies Intervention:   Drug: Supra-Pharmacologic Dexamethasone sodium phosphate Sponsors:   AVM Biotechnology LLC;   Medpace, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials